SEC Form 4 · accession 0001209191-16-109439
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Mar 16, 2016
Accepted (ET)
Mar 18, 2016 · 3:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2016 | M | 5,130 | $35.35 | A | 270,414 | D | |
| Common StockF2,F3 | Mar 16, 2016 | S | 1,300 | $78.07 | D | 269,114 | D | |
| Common StockF2,F4 | Mar 16, 2016 | S | 1,533 | $79.00 | D | 267,581 | D | |
| Common StockF2,F5 | Mar 16, 2016 | S | 1,197 | $79.98 | D | 266,384 | D | |
| Common StockF2,F6 | Mar 16, 2016 | S | 300 | $81.00 | D | 266,084 | D | |
| Common StockF2,F7 | Mar 16, 2016 | S | 600 | $82.27 | D | 265,484 | D | |
| Common StockF2 | Mar 16, 2016 | S | 200 | $82.98 | D | 265,284 | D | |
| Common Stock | holding | — | — | — | 13,286 | I | 401k | |
| Common Stock | holding | — | — | — | 122,700 | I | Common Stock Held In Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F8 | $35.35 | Mar 16, 2016 | M | 5,130 | D | — | Jul 19, 2016 | Common Stock | 5,130 | 82,090 | D |
Explanation of responses
- F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- F2Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F3Open market sales reported on this line occurred at a weighted average price of $78.07 (range $77.71 to $78.62).
- F4Open market sales reported on this line occurred at a weighted average price of $79.00 (range $78.73 to $79.45).
- F5Open market sales reported on this line occurred at a weighted average price of $79.98 (range $79.74 to $80.31).
- F6Open market sales reported on this line occurred at a weighted average price of $81.00 (range $80.92 to $81.12).
- F7Open market sales reported on this line occurred at a weighted average price of $82.27 (range $81.94 to $82.79).
- F8Fully vested.